Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth B Coffelt

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Blood|May 21, 2009
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaHsin-Yu Fang, Russell Hughes, Craig Murdoch, et al.
Science Translational Medicine|June 22, 2018
The ERBB network facilitates KRAS-driven lung tumorigenesisBjörn Kruspig, Tiziana Monteverde, Sarah Neidler, et al.
European Journal of Immunology|October 11, 2021
Monocytes mediate Salmonella Typhimurium-induced tumor growth inhibition in a mouse melanoma modelSíle A Johnson, Michael J Ormsby, Hannah M Wessel, et al.
Oncoimmunology|September 19, 2017
Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophagesKelly Kersten, Seth B Coffelt, Marlous Hoogstraat, et al.
Oncogene|September 6, 2024
Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expressionAntonia M D Churchhouse, Caroline V Billard, Toshiyasu Suzuki, et al.
Cancer Research|January 15, 2011
Use of macrophages to target therapeutic adenovirus to human prostate tumorsMunitta Muthana, Athina Giannoudis, Simon D Scott, et al.
Cell Discovery|June 4, 2024
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissueSaumya Kumar, Afonso P Basto, Filipa Ribeiro, et al.
Nature Cell Biology|March 20, 2019
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon responseCamilla Salvagno, Metamia Ciampricotti, Sander Tuit, et al.
Nature Immunology|May 27, 2024
Perinatal thymic-derived CD8αβ-expressing γδ T cells are innate IFN-γ producers that expand in IL-7R-STAT5B-driven neoplasmsNital Sumaria, Gina J Fiala, Daniel Inácio, et al.
Cancer Discovery|March 23, 2020
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal AdenocarcinomaNathiya Muthalagu, Tiziana Monteverde, Ximena Raffo-Iraolagoitia, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Blood|May 21, 2009
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaHsin-Yu Fang, Russell Hughes, Craig Murdoch, et al.
Science Translational Medicine|June 22, 2018
The ERBB network facilitates KRAS-driven lung tumorigenesisBjörn Kruspig, Tiziana Monteverde, Sarah Neidler, et al.
European Journal of Immunology|October 11, 2021
Monocytes mediate Salmonella Typhimurium-induced tumor growth inhibition in a mouse melanoma modelSíle A Johnson, Michael J Ormsby, Hannah M Wessel, et al.
Oncoimmunology|September 19, 2017
Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophagesKelly Kersten, Seth B Coffelt, Marlous Hoogstraat, et al.
Oncogene|September 6, 2024
Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expressionAntonia M D Churchhouse, Caroline V Billard, Toshiyasu Suzuki, et al.
Cancer Research|January 15, 2011
Use of macrophages to target therapeutic adenovirus to human prostate tumorsMunitta Muthana, Athina Giannoudis, Simon D Scott, et al.
Cell Discovery|June 4, 2024
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissueSaumya Kumar, Afonso P Basto, Filipa Ribeiro, et al.
Nature Cell Biology|March 20, 2019
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon responseCamilla Salvagno, Metamia Ciampricotti, Sander Tuit, et al.
Nature Immunology|May 27, 2024
Perinatal thymic-derived CD8αβ-expressing γδ T cells are innate IFN-γ producers that expand in IL-7R-STAT5B-driven neoplasmsNital Sumaria, Gina J Fiala, Daniel Inácio, et al.
Cancer Discovery|March 23, 2020
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal AdenocarcinomaNathiya Muthalagu, Tiziana Monteverde, Ximena Raffo-Iraolagoitia, et al.
Pageof 7